Anzeige
Mehr »
Login
Mittwoch, 08.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Diese Aktie hebt ab: +130,67% Kursgewinn in 1 Monat – das sind die Gründe
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
119 Leser
Artikel bewerten:
(0)

Mooreland Partners Advises Cambridge Medical Robotics on its $20 million Series A Financing

Mooreland Maintains Deal Momentum in the Robotics Sector

LONDON, July 18, 2016 /PRNewswire/ --Mooreland Partners, the leading independent investment bank providing M&A and private capital advisory services to the global technology industry, today announced that it acted as the exclusive financial advisor to Cambridge Medical Robotics (CMR) on its recently completed Series A equity financing from new investorsLGT Global Invest, ABB Technology Ventures (ABB) and Cambridge Innovation Capital. This transaction further strengthens Mooreland Partners' position as a leading global M&A and private capital advisor on transatlantic strategic transactions in the Robotics segment.

Logo - http://photos.prnewswire.com/prnh/20141029/155139LOGO

Headquartered in Cambridge, England, CMR is developing the next-generation universal robotic system for minimal access (or "keyhole") surgery. The company's vision is to make minimal access surgery universally accessible and affordable by expanding the range of procedures that can be performed robotically. The CMR robotic arm and end-of-arm surgical instruments provide significantly enhanced flexibility, mimicking the dexterity of the surgeon's hands. This lifelike sensitivity and usability has been lacking in surgical robotic systems currently on the market.

Following the successful start of clinical cadaveric trials in June 2016, investment proceeds will enable CMR to continue on its path toward becoming a global medical device manufacturer. Specifically, the proceeds will be used to advance development and commercialization of its medical robotic technology, and to expand the team in preparation for regulatory approval.

"As CMR prepares for its next phase of development, the company will benefit enormously from this strong and diverse investor group that includes a leading global player in the robotics field (ABB), and some of the best known institutional investors in Europe," said Victor Garcia, Managing Director at Mooreland.

ABOUT MOORELAND PARTNERS
Founded in 2002, Mooreland Partners is a leading independent investment bank providing M&A and private capital advisory services to the global technology industry, serving clients from its offices in London, New York, and Silicon Valley. Mooreland's team of nearly 50 professionals delivers industry domain and transaction expertise across all major technology sectors including industrial technology and electronics, enterprise software and services, communications technology, as well as digital media and internet. Learn more at www.moorelandpartners.com; read our blog.

All trademarks contained herein are the property of their respective owners.

MEDIA CONTACT
press@moorelandpartners.com
Tel. +1 212 653 0800

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.